Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
CervoMed
(NASDAQ:CRVO)
Intraday
$22.25
-2.45
[-9.92%]
After-Hours
$22.25
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$22.25
-2.45
[-9.92%]
At close: May 8
$22.25
0
[0.00%]
After Hours: 7:03AM EDT
Get Report
Watch
Q1 2024 Earnings were released on Tue May 14th, after the market close
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for CervoMed Stock (NASDAQ:CRVO)
CervoMed Stock (NASDAQ: CRVO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, May 15, 2024
CervoMed Q1 EPS $(0.41) Misses $(0.39) Estimate, Sales $2.35M Beat $1.35M Estimate
Benzinga Newsdesk
-
10 hours ago
Monday, April 15, 2024
CRVO: $150 Million Financing Strengthens Balance Sheet; Topline Data for Phase 2b Trial in 4Q24
Zacks Small Cap Research
-
Apr 15, 2024, 12:49PM
Monday, April 08, 2024
Disney To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday
Avi Kapoor
-
Apr 8, 2024, 8:00AM
Canaccord Genuity Maintains Buy on CervoMed, Raises Price Target to $65
Benzinga Newsdesk
-
Apr 8, 2024, 7:37AM
Thursday, March 28, 2024
CervoMed shares are trading higher after the company announced a private placement financing.
Benzinga Newsdesk
-
Mar 28, 2024, 8:48AM
CervoMed Announces Private Placement Financing Including $50M Financing Upfront With Up To An Additional $99.4M Tied To Exercise Of Warrants
Benzinga Newsdesk
-
Mar 28, 2024, 8:35AM
Thursday, March 21, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Mar 21, 2024, 1:31PM
Tuesday, March 05, 2024
CervoMed Announces Presentation Of Biomarker Data From The AscenD-LB Phase 2a Trial And Preclinical Data Supporting Potential Of Neflamapimod In Tau-Mediated Disease At AD/PD 2024
Benzinga Newsdesk
-
Mar 5, 2024, 8:01AM
Thursday, February 15, 2024
Canaccord Genuity Initiates Coverage On CervoMed with Buy Rating, Announces Price Target of $50
Benzinga Newsdesk
-
Feb 15, 2024, 7:18AM
Monday, February 12, 2024
CervoMed Publishes Results From AscenD-LB Phase 2a Trial Evaluating Treatment Of Neflamapimod In Dementia With Lewy Bodies
Benzinga Newsdesk
-
Feb 12, 2024, 8:08AM
Wednesday, February 07, 2024
CervoMed Appoints Joshua Boger As Board Chair
Benzinga Newsdesk
-
Feb 7, 2024, 8:35AM
Monday, November 06, 2023
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Nov 6, 2023, 8:06AM
Wednesday, October 25, 2023
CervoMed Announced Oral Presentation At CTAD 2023 Highlighting Learnings from Phase 2a Which Optimized Design Of Phase 2b Clinical Study Of Neflamapimod In Dementia With Lewy Bodies
Charles Gross
-
Oct 25, 2023, 2:51PM
Friday, October 20, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Oct 20, 2023, 5:31PM
Thursday, September 07, 2023
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Sep 7, 2023, 1:31PM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Sep 7, 2023, 9:06AM
Thursday, August 31, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Aug 31, 2023, 5:31PM
Monday, August 28, 2023
AI EIPP Holdings Llc Reports 9.99% Passive Stake In Cervomed Inc. As Of Aug 16
Benzinga Newsdesk
-
Aug 28, 2023, 4:08PM
Friday, August 18, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Aug 18, 2023, 1:31PM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Aug 18, 2023, 9:06AM
Thursday, August 17, 2023
Cervomed Shares Begin Trading On Nasdaq Following Completion Of Merger Of Diffusion Pharma And EIP Pharma
Charles Gross
-
Aug 17, 2023, 7:46AM
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch